首页> 美国卫生研究院文献>Molecular Medicine Reports >Effect of RNA interference of the expression of HMGA2 on the proliferation and invasion ability of ACHN renal cell carcinoma cells
【2h】

Effect of RNA interference of the expression of HMGA2 on the proliferation and invasion ability of ACHN renal cell carcinoma cells

机译:RNA干扰HMGA2表达对ACHN肾癌细胞增殖和侵袭能力的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

This aim of the present study was to observe the effect of high mobility group AT-hook 2 (HMGA2) on the proliferation and invasion ability of ACHN renal cell carcinoma (RCC) cells. Human ACHN cells, an RCC cell line, and HKC normal human renal tubular epithelial cells were cultured. HMGA2 small interfering (si)RNA, Mock-siRNA and their negative control group were designed and synthesized. Subsequently, the ACHN cells were transiently transfected using RNA interference technology. Finally, the mRNA and protein expression levels of HMGA2 were detected using reverse transcription-polymerase chain reaction and western blot analyses. The proliferation ability of the ACHN cells was determined using MTT, and ACHN cell invasion ability was detected using the Transwell method. The results showed that the mRNA and protein expression levels of HMGA2 in the ACHN cells were considerably higher, compared with those in the HKC cells (P<0.01). The RCC cells, in which the expression of HMGA2 was specifically silenced, was successfully constructed. The proliferation rate of cells in the HMGA2-siRNA group was significantly lower, compared with that of cells in the Mock-siRNA group and control group at 24, 48, 72 and 96 h post-transfection (P<0.05). The invasion ability of cells in the HMGA2-siRNA group was significantly lower, compared with that of cells in the Mock-siRNA group and control group (P<0.05) 48 h following transfection. Therefore, the HMGA2 gene may function as an oncogene in the occurrence and development of RCC, and provide specific targets for the targeted therapy of RCC. Further detailed investigations of the HMGA2 gene are important for future gene therapy of RCC.
机译:本研究的目的是观察高迁移率组AT-hook 2(HMGA2)对ACHN肾细胞癌(RCC)细胞增殖和侵袭能力的影响。培养人ACHN细胞,RCC细胞系和HKC正常人肾小管上皮细胞。设计合成了HMGA2小干扰(si)RNA,Mock-siRNA及其阴性对照组。随后,使用RNA干扰技术瞬时转染ACHN细胞。最后,通过逆转录-聚合酶链反应和蛋白质印迹分析检测了HMGA2的mRNA和蛋白质表达水平。使用MTT测定ACHN细胞的增殖能力,并使用Transwell法检测ACHN细胞的侵袭能力。结果表明,与HKC细胞相比,ACHN细胞中HMGA2的mRNA和蛋白表达水平显着较高(P <0.01)。成功构建了其中的HMGA2表达被特异性沉默的RCC细胞。转染后24、48、72和96 h,HMGA2-siRNA组细胞的增殖率明显低于Mock-siRNA组和对照组的细胞增殖率(P <0.05)。转染后48 h,HMGA2-siRNA组细胞的侵袭能力明显低于Mock-siRNA组和对照组(P <0.05)。因此,HMGA2基因可能在RCC的发生和发展中起癌基因的作用,并为RCC的靶向治疗提供特定的靶标。 HMGA2基因的进一步详细研究对于RCC的未来基因治疗很重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号